|
FY2025
12 months to Dec 31, 2025
|
FY2023
12 months to Jun 30, 2024
|
FY2022
12 months to Jun 30, 2023
|
|
|---|---|---|---|
| Cash Flows from Operating Activities | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Origination and purchase of investments | |||
| Payment in-kind interest and dividends | |||
| Sales and repayments of investments | |||
| Net realized (gain) loss on investments | |||
| Net change in unrealized appreciation/depreciation on investments | |||
| Amortization of discount/premium on investments | |||
| Amortization of deferred debt issuance costs | |||
| Amortization of original issue discount | |||
| Net (increase) decrease in operating assets: | |||
| Principal receivable | |||
| Interest receivable | |||
| Payment-in-kind interest receivable | |||
| Short-term receivable | |||
| Long-term receivable | |||
| Escrow receivable | |||
| Other receivables | |||
| Prepaid expenses and other assets | |||
| Net increase (decrease) in operating liabilities: | |||
| Payable for investments purchased | |||
| Interest payable | |||
| Base management fees payable | |||
| Income-based incentive fees payable | |||
| Deferred income liability | |||
| Directors fees payable | |||
| Accrued expenses and other liabilities | |||
| Net cash (used in) provided by operating activities | |||
| Cash Flows from Financing Activities: | |||
| Payments for deferred financing costs | |||
| Issuance of common shares | |||
| Repurchases of common shares | |||
| Distributions to stockholders | |||
| Repayments of Term loan | |||
| Proceeds from 2026 Notes, net | |||
| Repayments of 2023 Notes | |||
| Proceeds from borrowing on revolving financing facility | |||
| Repayments of borrowing on revolving financing facility | |||
| Net cash (used in) provided by financing activities | |||
| Net change in cash and cash equivalents | |||
| Cash and cash equivalents and restricted cash and cash equivalents at beginning of period | |||
| Cash and cash equivalents and restricted cash and cash equivalents at end of period | |||
| Supplemental and non-cash financing cash flow information: | |||
| Cash paid for interest | |||
| Cash paid for taxes | |||
| Issuance of shares pursuant to Dividend Reinvestment Plan | |||
| Non-cash purchase of investments | |||
| Non-cash sale of investments | |||
| Cash and cash equivalents | |||
| Restricted cash and cash equivalents |
Loading...